T0	Participants 102 133	in HIV-HCV-coinfected patients:
T1	Participants 309 339	in HIV-HCV-coinfected patients
T2	Participants 341 398	METHODS HIV and HCV genotype 1- and 4-coinfected subjects
T3	Participants 885 930	RESULTS A total of 67 patients were included;